These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19557165)

  • 1. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.
    Chang TH; Kubota T; Matsuoka M; Jones S; Bradfute SB; Bray M; Ozato K
    PLoS Pathog; 2009 Jun; 5(6):e1000493. PubMed ID: 19557165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.
    Leung LW; Park MS; Martinez O; Valmas C; López CB; Basler CF
    Immunol Cell Biol; 2011 Oct; 89(7):792-802. PubMed ID: 21263462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.
    Yen B; Mulder LC; Martinez O; Basler CF
    J Virol; 2014 Nov; 88(21):12500-10. PubMed ID: 25142601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function.
    Shabman RS; Leung DW; Johnson J; Glennon N; Gulcicek EE; Stone KL; Leung L; Hensley L; Amarasinghe GK; Basler CF
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S911-8. PubMed ID: 21987769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.
    Jin H; Yan Z; Prabhakar BS; Feng Z; Ma Y; Verpooten D; Ganesh B; He B
    J Gen Virol; 2010 Feb; 91(Pt 2):352-61. PubMed ID: 19828757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
    Yen BC; Basler CF
    J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
    Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
    Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evasion of interferon responses by Ebola and Marburg viruses.
    Basler CF; Amarasinghe GK
    J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
    Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
    Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells.
    Feagins AR; Basler CF
    Virology; 2015 Nov; 485():145-52. PubMed ID: 26255028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the Ebola Virus VP24 Protein by SUMO.
    Vidal S; El Motiam A; Seoane R; Preitakaite V; Bouzaher YH; Gómez-Medina S; San Martín C; Rodríguez D; Rejas MT; Baz-Martínez M; Barrio R; Sutherland JD; Rodríguez MS; Muñoz-Fontela C; Rivas C
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.
    Basler CF; Mikulasova A; Martinez-Sobrido L; Paragas J; Mühlberger E; Bray M; Klenk HD; Palese P; García-Sastre A
    J Virol; 2003 Jul; 77(14):7945-56. PubMed ID: 12829834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3.
    Li R; Pan Y; Shi DD; Zhang Y; Zhang J
    Antiviral Res; 2013 Nov; 100(2):546-54. PubMed ID: 24036127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
    Prins KC; Delpeut S; Leung DW; Reynard O; Volchkova VA; Reid SP; Ramanan P; Cárdenas WB; Amarasinghe GK; Volchkov VE; Basler CF
    J Virol; 2010 Mar; 84(6):3004-15. PubMed ID: 20071589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
    Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
    Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
    Hartman AL; Dover JE; Towner JS; Nichol ST
    J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
    Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
    J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
    Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.